These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2499244)

  • 1. The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Smith TW; Davis MA; Pang RH
    Ann Neurol; 1989 Mar; 25(3):281-5. PubMed ID: 2499244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH
    Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic drugs prevent pericardial adhesions in the rabbit.
    Wiseman DM; Kamp L; Linsky CB; Jochen RF; Pang RH; Scholz PM
    J Surg Res; 1992 Oct; 53(4):362-8. PubMed ID: 1405617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits.
    Lapchak PA; Araujo DM; Pakola S; Song D; Wei J; Zivin JA
    Stroke; 2002 Sep; 33(9):2279-84. PubMed ID: 12215599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
    Muramatsu H; Igarashi H; Okubo S; Katayama Y
    Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.
    del Zoppo GJ; Poeck K; Pessin MS; Wolpert SM; Furlan AJ; Ferbert A; Alberts MJ; Zivin JA; Wechsler L; Busse O
    Ann Neurol; 1992 Jul; 32(1):78-86. PubMed ID: 1642475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress after thrombolysis-induced reperfusion in human stroke.
    Domínguez C; Delgado P; Vilches A; Martín-Gallán P; Ribó M; Santamarina E; Molina C; Corbeto N; Rodríguez-Sureda V; Rosell A; Alvarez-Sabín J; Montaner J
    Stroke; 2010 Apr; 41(4):653-60. PubMed ID: 20185784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion.
    Miyazaki T; Kimura Y; Ohata H; Hashimoto T; Shibata K; Hasumi K; Honda K
    Stroke; 2011 Apr; 42(4):1097-104. PubMed ID: 21350203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion.
    Lu A; Kurosawa Y; Luskey K; Pyne-Geithman G; Caudell D; Clark J
    Neurol Res; 2009 Mar; 31(2):209-14. PubMed ID: 19298764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke.
    Lew SM; Gross CE; Bednar MM; Russell SJ; Fuller SP; Ellenberger CL; Howard D
    Brain Res Bull; 1999 Feb; 48(3):325-31. PubMed ID: 10229342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.